Secular Trends in Use of Disease Modifying Anti-Rheumatic Drugs for the Treatment of Rheumatoid Arthritis in the United States

被引：0
|
作者：
Desai, Rishi J. [1 ]
Solomon, Daniel H. [2 ]
Liu, Jun [3 ]
Kim, Seoyoung C. [4 ]
机构：
[1] Brigham & Womens Hosp, PharmacoEpidemiol & PharmacoEcon, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Rheumatol, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Div Pharmacoepidemiol, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2725
引用
收藏
页数：2
相关论文
共 50 条
  • [31] DISEASE MODIFYING ANTI-RHEUMATIC DRUGS
    STECHER, VJ
    CARLSON, JA
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, 1983, 18 : 171 - 179
  • [32] USE OF BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS WITH OR WITHOUT METHOTREXATE FOR TREATMENT OF RHEUMATOID ARTHRITIS: A SINGLE CENTRE EXPERIENCE
    Leng, Pisaniello Huai
    Karen, O'Brien
    Malcolm, Smith
    Fiona, Goldblatt
    INTERNAL MEDICINE JOURNAL, 2016, 46 : 29 - 29
  • [33] Adverse drug reactions associated with the use of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis
    Enrique Machado-Alba, Jorge
    Felipe Ruiz, Andres
    Enrique Machado-Duque, Manuel
    REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2014, 36 (06): : 396 - 401
  • [34] A narrative review of the comparative safety of disease-modifying anti-rheumatic drugs used for the treatment of rheumatoid arthritis
    Sen, Rouhin
    Riofrio, Maria
    Singh, Jasvinder A.
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (06) : 687 - 714
  • [35] Treatment of early rheumatoid arthritis in developing countries. Biologics or disease-modifying anti-rheumatic drugs?
    Yen, J. -H.
    BIOMEDICINE & PHARMACOTHERAPY, 2006, 60 (10) : 688 - 692
  • [36] Development of a nursing practice scale for rheumatoid arthritis treatment with biological disease-modifying anti-rheumatic drugs
    Song, Fang
    Nakatani, Hisae
    Sugiyama, Eiji
    Hirata, Shintaro
    MODERN RHEUMATOLOGY, 2024, 34 (03) : 479 - 487
  • [37] Advances in the implications of the gut microbiota on the treatment efficacy of disease-modifying anti-rheumatic drugs in rheumatoid arthritis
    Fan, Junyu
    Jiang, Ting
    He, Dongyi
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [38] Vaccinations in adults with rheumatoid arthritis in an era of new disease-modifying anti-rheumatic drugs
    Meroni, P. L.
    Zavaglia, D.
    Girmenia, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (02) : 317 - 328
  • [39] Utilization of biologic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancer
    Xerxes Pundole
    Natalia V. Zamora
    Harish Siddhanamatha
    Heather Lin
    Jean Tayar
    Leung Cheuk Hong
    Liang Li
    Maria E. Suarez-Almazor
    Clinical Rheumatology, 2020, 39 : 787 - 794
  • [40] Utilization of biologic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancer
    Pundole, Xerxes
    Zamora, Natalia V.
    Siddhanamatha, Harish
    Lin, Heather
    Tayar, Jean
    Hong, Leung Cheuk
    Li, Liang
    Suarez-Almazor, Maria E.
    CLINICAL RHEUMATOLOGY, 2020, 39 (03) : 787 - 794
12345